| scholarly article | Q13442814 |
| P50 | author | Nyla A Heerema | Q89317565 |
| P2093 | author name string | Soheil Meshinchi | |
| Rong Zeng | |||
| Alan S Gamis | |||
| Robert B Gerbing | |||
| Todd A Alonzo | |||
| Phoenix A Ho | |||
| Susana C Raimondi | |||
| Betsy A Hirsch | |||
| Jessica A Pollard | |||
| Beverly Lange | |||
| Janet L Franklin | |||
| Julia Kuhn | |||
| Kristen L Miller | |||
| P2860 | cites work | WT1 proteins: functions in growth and differentiation | Q28191433 |
| RNA editing in the Wilms' tumor susceptibility gene, WT1 | Q28238638 | ||
| A "silent" polymorphism in the MDR1 gene changes substrate specificity | Q29619435 | ||
| Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. | Q34052581 | ||
| Hearing silence: non-neutral evolution at synonymous sites in mammals | Q34485607 | ||
| Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group | Q36407162 | ||
| Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances | Q36719212 | ||
| Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics | Q37240557 | ||
| SNPs: impact on gene function and phenotype | Q37600710 | ||
| Silent (synonymous) SNPs: should we care about them? | Q37600712 | ||
| Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia | Q38347620 | ||
| Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells | Q40176645 | ||
| Expression of the Wilms' tumor gene (WT1) in human leukemias | Q53490672 | ||
| Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study. | Q54465378 | ||
| Synonymous codon substitutions affect ribosome traffic and protein folding during in vitro translation | Q73327926 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| acute myeloid leukemia | Q264118 | ||
| single-nucleotide polymorphism | Q501128 | ||
| childhood acute myeloid leukemia | Q55779816 | ||
| P304 | page(s) | 704-711 | |
| P577 | publication date | 2010-12-28 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group | |
| P478 | volume | 29 |
| Q40133142 | A genomic variant in IRF9 is associated with serum cytokine levels in pig. |
| Q38661750 | A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia. |
| Q28259425 | APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcripts |
| Q34749589 | Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia |
| Q44586307 | Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 in de novo non-M3 acute myeloid leukemia |
| Q54490632 | Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia. |
| Q33397024 | Array CGH in human leukemia: from somatics to genetics |
| Q35666497 | Association between WT1 polymorphisms and susceptibility to breast cancer: results from a case-control study in a southwestern Chinese population |
| Q34622289 | Associations between variants of the HAL gene and milk production traits in Chinese Holstein cows |
| Q27005960 | Childhood acute myeloid leukaemia |
| Q38068816 | Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia |
| Q35265946 | Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study |
| Q36362927 | Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology Group. |
| Q37645063 | Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients. |
| Q37125803 | High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group |
| Q37567685 | Homology modeling and molecular dynamics studies of Wilms' tumor gene 1 frameshift mutations in exon 7. |
| Q45946946 | Investigating DNA-, RNA-, and protein-based features as a means to discriminate pathogenic synonymous variants. |
| Q36919799 | Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation |
| Q43166287 | Low frequency of type-I and type-II aberrations in myeloid leukemia of Down syndrome, underscoring the unique entity of this disease |
| Q30449310 | Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa |
| Q52594783 | Molecular cloning, polymorphism, and expression analysis of the LKB1/STK11 gene and its association with non-specific digestive disorder in rabbits. |
| Q47254894 | Polymorphisms in genes related to epithelial-mesenchymal transition and risk of non-small cell lung cancer |
| Q35525313 | Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG |
| Q35332133 | Risk-Reducing Genetic Variant of Wilms Tumor 1 Gene rs16754 in Korean Patients With BCR-ABL1-Negative Myeloproliferative Neoplasm |
| Q54343007 | Single nucleotide polymorphism of Wilms' tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia. |
| Q34618828 | Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma |
| Q36940760 | Single nucleotide polymorphisms of CD20 gene and their relationship with clinical efficacy of R-CHOP in patients with diffuse large B cell lymphoma |
| Q37362606 | The Wilms Tumor-1 (WT1) rs16754 polymorphism is a prognostic factor in acute myeloid leukemia (AML): a meta-analysis |
| Q57997303 | The Wilms Tumor-1 (WT1) rs2234593 variant is a prognostic factor in normal karyotype acute myeloid leukemia |
| Q45909731 | The many facets of WT1 in acute myeloid leukemia: clarity remains elusive. |
| Q45012427 | The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group. |
| Q34261528 | Transcriptional enhancers in protein-coding exons of vertebrate developmental genes |
| Q37924093 | Understanding the contribution of synonymous mutations to human disease |
| Q50498738 | WT1 Mutation in Childhood Cancer. |
| Q48882411 | WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia |
| Q41532291 | Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia |
| Q84562445 | Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia |
Search more.